Published in South Med J on June 01, 2007
Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21
A common allele on chromosome 9 associated with coronary heart disease. Science (2007) 20.37
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet (2012) 12.10
Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet (2012) 7.59
A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat Genet (2009) 6.31
Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest (2008) 6.25
The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation. J Am Coll Cardiol (2013) 4.81
Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler Thromb Vasc Biol (2010) 4.08
Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes (2010) 4.07
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21
Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study: A Genome-wide association meta-analysis involving more than 22 000 cases and 60 000 controls. Circ Cardiovasc Genet (2010) 3.15
Gene dosage of the common variant 9p21 predicts severity of coronary artery disease. J Am Coll Cardiol (2010) 3.07
Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus. Arterioscler Thromb Vasc Biol (2009) 2.79
Rare copy number variation discovery and cross-disorder comparisons identify risk genes for ADHD. Sci Transl Med (2011) 2.29
Genetically determined height and coronary artery disease. N Engl J Med (2015) 2.24
Disruption at the PTCHD1 Locus on Xp22.11 in Autism spectrum disorder and intellectual disability. Sci Transl Med (2010) 1.75
Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy. Circulation (2004) 1.72
Kinesin family member 6 variant Trp719Arg does not associate with angiographically defined coronary artery disease in the Ottawa Heart Genomics Study. J Am Coll Cardiol (2009) 1.64
American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract (2004) 1.59
Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease. Circulation (2003) 1.56
Myozenin 2 is a novel gene for human hypertrophic cardiomyopathy. Circ Res (2007) 1.51
Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants. Stroke (2013) 1.51
The cloning, genomic organization and tissue expression profile of the human DLG5 gene. BMC Genomics (2002) 1.50
American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract (2004) 1.47
Blood pressure loci identified with a gene-centric array. Am J Hum Genet (2011) 1.44
A 53-year-old man with fever, clubbing, hemoptysis, and rapid onset of respiratory failure. Chest (2007) 1.41
Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome. Circulation (2004) 1.35
A genome-wide association study for coronary artery disease identifies a novel susceptibility locus in the major histocompatibility complex. Circ Cardiovasc Genet (2012) 1.35
Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circ Res (2005) 1.34
Differential interactions of thin filament proteins in two cardiac troponin T mouse models of hypertrophic and dilated cardiomyopathies. Cardiovasc Res (2008) 1.33
Improved prediction of cardiovascular disease based on a panel of single nucleotide polymorphisms identified through genome-wide association studies. Circ Cardiovasc Genet (2010) 1.23
Genome-wide mapping of modifier chromosomal loci for human hypertrophic cardiomyopathy. Hum Mol Genet (2007) 1.23
PRKAG2 cardiac syndrome: familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy. Curr Opin Cardiol (2002) 1.19
Interferon-γ activates expression of p15 and p16 regardless of 9p21.3 coronary artery disease risk genotype. J Am Coll Cardiol (2012) 1.15
Clinical and genetic association of serum paraoxonase and arylesterase activities with cardiovascular risk. Arterioscler Thromb Vasc Biol (2012) 1.10
Clinical and genetic association of serum ceruloplasmin with cardiovascular risk. Arterioscler Thromb Vasc Biol (2011) 1.10
Comparative genome-wide association studies in mice and humans for trimethylamine N-oxide, a proatherogenic metabolite of choline and L-carnitine. Arterioscler Thromb Vasc Biol (2014) 1.08
Evolution of expression of cardiac phenotypes over a 4-year period in the beta-myosin heavy chain-Q403 transgenic rabbit model of human hypertrophic cardiomyopathy. J Mol Cell Cardiol (2004) 1.03
Overlooked and underserved: "action signs" for identifying children with unmet mental health needs. Pediatrics (2011) 1.02
Determinants of cardiac electrophysiological properties in mice. J Interv Card Electrophysiol (2004) 1.02
Circulating brain-derived neurotrophic factor concentrations and the risk of cardiovascular disease in the community. J Am Heart Assoc (2015) 0.96
The transcription factor GATA-2 does not associate with angiographic coronary artery disease in the Ottawa Heart Genomics and Cleveland Clinic GeneBank Studies. Hum Genet (2009) 0.92
Assessment of the 9p21.3 locus in severity of coronary artery disease in the presence and absence of type 2 diabetes. BMC Med Genet (2013) 0.90
Genome-wide association studies of hypertension: have they been fruitful? J Cardiovasc Transl Res (2010) 0.88
Genomics in coronary artery disease: past, present and future. Can J Cardiol (2010) 0.88
Distinct early signaling events resulting from the expression of the PRKAG2 R302Q mutant of AMPK contribute to increased myocardial glycogen. Circ Cardiovasc Genet (2009) 0.88
A case of fatal necrotizing pancreatitis: complication of hydrochlorothiazide and lisinopril therapy. Dig Dis Sci (2007) 0.87
RANTES/CCL5 and risk for coronary events: results from the MONICA/KORA Augsburg case-cohort, Athero-Express and CARDIoGRAM studies. PLoS One (2011) 0.87
A prospective follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy--the Baylor experience (1996-2002). Clin Cardiol (2005) 0.85
Cardiac biomarkers for detection of myocardial infarction: perspectives from past to present. Clin Chem (2004) 0.84
Haptoglobin, the good and the bad: is it evidence based? J Am Coll Cardiol (2013) 0.84
Two chromosome 9p21 haplotype blocks distinguish between coronary artery disease and myocardial infarction risk. Circ Cardiovasc Genet (2013) 0.83
Unusual complication of heparin-induced thrombocytopenia after mitral valve surgery: spontaneous rupture of spleen. Ann Thorac Surg (2007) 0.83
The relationship between obesity and psychiatric disorders across ethnic and racial minority groups in the United States. Eat Behav (2010) 0.83
Genetic basis and pathogenesis of familial WPW syndrome. Indian Pacing Electrophysiol J (2003) 0.81
Personalized cardiovascular medicine: status in 2012. Can J Cardiol (2012) 0.81
Universal health care. Am Heart Hosp J (2007) 0.81
Can an energy-deficient heart grow bigger and stronger? J Am Coll Cardiol (2003) 0.80
Genomic view of factors leading to plaque instability. Curr Cardiol Rep (2009) 0.80
Creating a genetic risk score for coronary artery disease. Curr Atheroscler Rep (2009) 0.79
Scrotal swelling and sarcoidosis. Am J Med (2006) 0.79
Pharmacogenetics in cardiovascular disease: the challenge of moving from promise to realization: concepts discussed at the Canadian Network and Centre for Trials Internationally Network Conference (CANNeCTIN), June 2009. Clin Cardiol (2013) 0.78
The cloning, genomic organization and tissue expression profile of the human DLG5 gene: Correction. BMC Genomics (2002) 0.78
A statement on ethics from the HEART Group. JACC Cardiovasc Imaging (2008) 0.78
Methicillin-resistant Staphylococcus aureus pneumonia after thoracic surgery: successful treatment with linezolid after failed vancomycin therapy. Ann Thorac Surg (2007) 0.78
Osborn wave in hypothermia from Vibrio vunificus sepsis unrelated to exposure. Int J Cardiol (2006) 0.77
Molecular cardiology and genetics in the 21st century--a primer. Curr Probl Cardiol (2006) 0.76
Genetic testing for early detection of individuals at risk of coronary heart disease and monitoring response to therapy: challenges and promises. Curr Atheroscler Rep (2011) 0.76
Clinical and pathologic manifestations of necrobiosis lipoidica-like skin involvement in sarcoidosis. Joint Bone Spine (2007) 0.76
Echocardiography: a requisite friend of the cardiac geneticist. J Am Soc Echocardiogr (2011) 0.75
The number one cause for sudden cardiac death in the young unravels. Cardiology (2009) 0.75
Positron molecular imaging, an in vivo glimpse of the genome. J Mol Cell Cardiol (2007) 0.75
Disrobing the emperor (heart) without destroying the dignity of super-normality. Circulation (2002) 0.75
PCSK9 inhibition--a new thrust in the prevention of heart disease: genetics does it again. Can J Cardiol (2013) 0.75
Another chromosomal locus for mitral valve prolapse: close but no cigar. Circulation (2005) 0.75
Reply: The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: more questions than answers? J Am Coll Cardiol (2014) 0.75
Identification of myofilament mutations: its role in the diagnosis and management of hypertrophic cardiomyopathy. Mayo Clin Proc (2008) 0.75
Transient hypogammaglobulinemia and severe atopic dermatitis: Open-label treatment with immunoglobulin in a case series. Allergy Rhinol (Providence) (2016) 0.75
Genome-wide association studies --do not judge a book by its cover. Rev Esp Cardiol (2010) 0.75
Glioblastoma multiforme disguised as sarcoidosis: pitfalls in diagnosis. South Med J (2007) 0.75
Family coronary heart disease: a call to action. Clin Cardiol (2010) 0.75
Genomics: is it ready for primetime? Med Clin North Am (2012) 0.75
The Editor's Roundtable: Health reform and its implications for cardiovascular medicine. Am J Cardiol (2010) 0.75
A genomic revolution for cardiovascular disease-a progress report at five years. Am Heart Hosp J (2011) 0.75
In memoriam: Burton E. Sobel a tribute from family, friends and colleagues October 21, 1937 - May 3, 2013. Exp Biol Med (Maywood) (2013) 0.75
The genetic landscape from single gene to polygenic disorders. Curr Opin Cardiol (2010) 0.75
The role of genetic risk factors in coronary artery disease. Curr Cardiol Rep (2014) 0.75
Report of the American Heart Association Task Force on Strategic Research Direction: executive summary. Circulation (2002) 0.75
Statin therapy in acute coronary syndrome. Am J Cardiol (2006) 0.75
Prolonged livestock exposure and elevated serum IgE associated with pulmonary fibrosis. South Med J (2006) 0.75
Definition, classification, and staging of the adult cardiomyopathies: a proposal for revision. J Card Fail (2004) 0.75